Description

Simple

Clinical

Overview

Fasudil has been investigated in Carotid Stenosis.

Pharmacology

Indication

Information currently not available.

Pharmacodynamic

Information currently not available.

Mechanism of action

Information currently not available.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with Fasudil
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
2,4-thiazolidinedione
The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Fasudil.
Abafungin
The therapeutic efficacy of Abafungin can be increased when used in combination with Fasudil.
Acarbose
The therapeutic efficacy of Acarbose can be increased when used in combination with Fasudil.
Acebutolol
The risk or severity of bradycardia can be increased when Fasudil is combined with Acebutolol.
Acepromazine
The risk or severity of hypotension can be increased when Acepromazine is combined with Fasudil.
Acetohexamide
The therapeutic efficacy of Acetohexamide can be increased when used in combination with Fasudil.
Acetyldigitoxin
Fasudil may increase the arrhythmogenic activities of Acetyldigitoxin.
Acetyldigoxin
Fasudil may increase the arrhythmogenic activities of Acetyldigoxin.
Adenosine
Adenosine may increase the arrhythmogenic activities of Fasudil.
Agmatine
Fasudil may increase the arrhythmogenic activities of Agmatine.
AICA ribonucleotide
The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Fasudil.
Ajmaline
Ajmaline may increase the arrhythmogenic activities of Fasudil.
Albaconazole
The therapeutic efficacy of Albaconazole can be increased when used in combination with Fasudil.
Albiglutide
The therapeutic efficacy of Albiglutide can be increased when used in combination with Fasudil.
Alcuronium
Fasudil may increase the neuromuscular blocking activities of Alcuronium.
Alfuzosin
The risk or severity of hypotension can be increased when Alfuzosin is combined with Fasudil.
Allicin
The therapeutic efficacy of Allicin can be increased when used in combination with Fasudil.
Alloin
The therapeutic efficacy of Alloin can be decreased when used in combination with Fasudil.
Alogliptin
The therapeutic efficacy of Alogliptin can be increased when used in combination with Fasudil.
Alprenolol
The risk or severity of bradycardia can be increased when Fasudil is combined with Alprenolol.